اخبار و اعلانات

 آمار

تعداد نشریات283
تعداد نشریات سازمان81
تعداد شماره‌ها2,720
تعداد مقالات30,985
تعداد مشاهده مقاله26,731,056
تعداد دریافت فایل اصل مقاله16,126,116
Alqaseer, K, Al-Khafajy, A. A. M, Almkhadhree, E. A. K. (1401). Serological and Molecular Detection of Human Brucellosis in Rural Areas in Wasit Province, Iraq. سامانه مدیریت نشریات علمی, 78(1), 369-378. doi: 10.22092/ari.2022.359002.2352
K Alqaseer; A. A. M Al-Khafajy; E. A. K Almkhadhree. "Serological and Molecular Detection of Human Brucellosis in Rural Areas in Wasit Province, Iraq". سامانه مدیریت نشریات علمی, 78, 1, 1401, 369-378. doi: 10.22092/ari.2022.359002.2352
Alqaseer, K, Al-Khafajy, A. A. M, Almkhadhree, E. A. K. (1401). 'Serological and Molecular Detection of Human Brucellosis in Rural Areas in Wasit Province, Iraq', سامانه مدیریت نشریات علمی, 78(1), pp. 369-378. doi: 10.22092/ari.2022.359002.2352
Alqaseer, K, Al-Khafajy, A. A. M, Almkhadhree, E. A. K. Serological and Molecular Detection of Human Brucellosis in Rural Areas in Wasit Province, Iraq. سامانه مدیریت نشریات علمی, 1401; 78(1): 369-378. doi: 10.22092/ari.2022.359002.2352

Serological and Molecular Detection of Human Brucellosis in Rural Areas in Wasit Province, Iraq

Archives of Razi Institute
مقاله 46، دوره 78، شماره 1، فروردین و اردیبهشت 2023، صفحه 369-378    اصل مقاله (593.21 K)
نوع مقاله: Original Articles
شناسه دیجیتال (DOI): 10.22092/ari.2022.359002.2352
نویسندگان
K Alqaseer* 1؛ A. A. M Al-Khafajy2؛ E. A. K Almkhadhree2
1Department of Basic Science, Faculty of Nursing, University of Kufa, Najaf, Iraq
2Department of Biology, College of Science, University of Wasit, Wasit, Iraq
چکیده
Brucellosis is endemic in Iraq, and annual surveys using advanced diagnostic assays are needed. This study aimed to investigate the prevalence of human brucellosis in rural areas in Wasit province using ELISA and PCR. A total of 276 serum samples were randomly obtained from participants from rural areas in the Wasit province. The results showed that out of 276 serum samples tested by ELISA, 30.07% were positive. Significantly, mild infection was increased compared to moderate, severe and highly severe infections. To confirm the species of Brucella, seropositive samples were tested by PCR assay targeting the BCSP31 gene for Brucella spp. and the IS711 gene for B. abortus and B. melitensis. Molecular findings confirmed 30.12% positive samples to Brucella spp., including 28% and 44% positives to B. abortus and B. melitensis, respectively, whereas 28% positive samples to other undifferentiated species of Brucella. Association between seropositivity and demographic risk factors, age and gender, were reported to be significantly higher among individuals aged 21-40 (41.91%) and lowered among those aged £20 years (13.56%). For gender, a high nominal positivity rate was detected in females (36.07%) than in males (28.37%). Association between the degree of severity of the infection and demographic risk factors recorded that mild infection (75%) was increased among individuals of £20 years, while moderate and severe infections were elevated significantly in groups of 21-40 and 41-60 years. The highly severe infections appeared in those aged 21-40 years (15.91%). Regarding gender, mild and moderate infections were elevated significantly in males; whereas severe and highly severe infections were increased significantly in females. In conclusion, this study is the first random epidemiological study investigating the prevalence of human brucellosis in rural areas in Iraq. Undifferentiated species of Brucella were detected in PCR-positive results. The incorporation of molecular techniques for the diagnosis will help resolve the Brucella genus and detection the primary sources that play roles in the transmission of infection.
کلیدواژه‌ها
Brucella melitensis؛ Brucella abortus؛ Enzyme-linked immunosorbent assay (ELISA)؛ Polymerase chain reaction (PCR)؛ Demographic risk factor
سایر فایل های مرتبط با مقاله
مراجع
  1. Scholz HC, Revilla-Fernández S, Al Dahouk S, Hammerl JA, Zygmunt MS, Cloeckaert A, et al. Brucella vulpis sp. nov., isolated from mandibular lymph nodes of red foxes (Vulpes vulpes). Int J Syst Evol Microbiol. 2016;66(5):2090-8.
  2. Rajendhran J. Genomic insights into Brucella. Infect Genet Evol. 2021;87:104635.
  3. Singh B, Dhand NK, Gill J. Economic losses occurring due to brucellosis in Indian livestock populations. Prev Vet Med. 2015;119(3-4):211-5.
  4. Blasco JM, Moreno E, Moriyón I. Brucellosis. Veterinary Vaccines. 2021. p. 295-316.
  5. Tuon FF, Gondolfo RB, Cerchiari N. Human‐to‐human transmission of Brucella–a systematic review. Trop Med Int Health. 2017;22(5):539-46.
  6. Głowacka P, Żakowska D, Naylor K, Niemcewicz M, Bielawska-Drozd A. Virulence Factors, Pathogenesis and Treatment. Pol J Microbiol. 2018;67(2):151-61.
  7. Zadsar M, Shirzadi MR, Zeynali M, Rasouli M, Karimi G. Human Brucellosis: Risks and prevalence among Iranian blood donors residing in endemic areas. Transfus Med Hemother. 2020;47(2):103-9.
  8. Ferrero MC, Paiva IMA, González FM, Baldi PC. Pathogenesis and immune response in Brucella infection acquired by the respiratory route. Microbes Infect. 2020;22(9):407-15.
  9. Tuohutaerbieke M, Li X, Yin Y, Chen W, Wu D, Mao Z, et al. The Characteristics, Prevalence, and Risk Factors of Drug-Induced Liver Injury Among Brucellosis Inpatients in Xinjiang, China. Front Pharmacol. 2021:1175.
  10. Carugati M, Kilonzo KG, Crump JA. Fever, bacterial zoonoses, and One Health in sub-Saharan Africa. Clin Med. 2019;19(5):375.
  11. Yagupsky P, Morata P, Colmenero JD. Laboratory diagnosis of human brucellosis. 2019;33(1):e00073-19.
  12. Rahimi H, Tukmechi A, Rashidian EJAB. Use of touch-down polymerase chain reaction to enhance the sensitivity of Brucella melitensis detection in raw milk. Clin Microbiol Rev. 2022;33(1):104-9.
  13. Guo J, Wang Y, Niu S, Li H, Tian Y, Yu S, et al. Highly sensitive fluorescence-linked immunosorbent assay for the determination of human IgG in serum using quantum dot nanobeads and magnetic Fe3O4 nanospheres. ACS Omega. 2020;5(36):23229-36.
  14. Al-Hassani MKA, Al-Gharban HA, foad Manher LJA-QJoPS. Application of Three Diagnostic Serologic Techniques to Detect of Dromedary Camel’ s Brucellosis. 2018;23(2):61-74.
  15. Lukambagire AS, Mendes ÂJ, Bodenham RF, McGiven JA, Mkenda NA, Mathew C, et al. Performance characteristics and costs of serological tests for brucellosis in a pastoralist community of northern Tanzania. Sci Rep. 2021;11(1):1-11.
  16. Garshasbi M, Ramazani A, Sorouri R, Javani S, Moradi S. Molecular detection of Brucella species in patients suspicious of Brucellosis from Zanjan, Iran. Braz J Microbiol. 2014;45:533-8.
  17. Mussie HM. Seroprevalence study of bovine brucellosis in cattle and humans in Bahir Dar Milk shade. Master of Science thesis. Addis Ababa University, Faculty of Veterinary Medicine, Debre Zeit, Ethiopia. Trop Biomed. 2005.
  18. Nawaz Z, Shafique M, Zahoor M, Siddique A, Ali S, Arshad R, et al. Sero-epidemiology and risk factor analysis of human brucellosis in Punjab, Pakistan: a cross sectional study. Trop Biomed. 2021;38(3):413-9.
  19. Tumwine G, Matovu E, Kabasa JD, Owiny DO, Majalija S. Human brucellosis: sero-prevalence and associated risk factors in agro-pastoral communities of Kiboga District, Central Uganda. BMC Public Health. 2015;15(1):1-8.
  20. Arvas G, Akkoyunlu Y, Acikgoz G. Brucella and importance of the fight against brucellosis. 2013;1(3):147.
  21. Madut NA, Nasinyama GW, Muma JB, Sube KL, Ocan M, Muwonge A, et al. Prevalence of brucellosis among patients attending Wau Hospital, South Sudan. Balkan J Health Sci. 2018;13(6):0199315.
  22. Chegeni AS, Ezatpour B, Saki M, Mokhayeri H, Adavi S, Nasiri E, et al. Seroepidemiology of human brucellosis in nomads in a rural area of Iran. Asian Pac J Trop Med. 2014;4(4):333-6.
  23. Al-Graibawi MA, Yousif AA, Gharban HA, Zinsstag J. First serodetection and molecular phylogenetic documentation of Coxiella burnetii isolates from female camels in Wasit governorate, Iraq. Iraqi J Vet Sci. 2021;35:47-52.
  24. Al Dahouk S, Nöckler K, Scholz HC, Pfeffer M, Neubauer H, Tomaso H. Evaluation of genus-specific and species-specific real-time PCR assays for the identification of Brucella spp. 2007.
  25. Al Dahouk S, Nöckler K. Implications of laboratory diagnosis on brucellosis therapy. Expert Rev Anti Infect Ther. 2011;9(7):833-45.
  26. Gómez MC, Nieto JA, Rosa C, Geijo P, Escribano MA, Munoz A, et al. Evaluation of seven tests for diagnosis of human brucellosis in an area where the disease is endemic. Clin Vaccine Immunol. 2008;15(6):1031-3.
  27. Khan MZ, Zahoor M. An overview of brucellosis in cattle and humans, and its serological and molecular diagnosis in control strategies. Trop Med Int Health. 2018;3(2):65.
  28. Mirnejad R, Jazi FM, Mostafaei S, Sedighi M. Molecular investigation of virulence factors of Brucella melitensis and Brucella abortus strains isolated from clinical and non-clinical samples. Microb Pathog. 2017;109:8-14.
  29. Baldi PC, Miguel SE, Fossati CA, Wallach J. Serological follow-up of human brucellosis by measuring IgG antibodies to lipopolysaccharide and cytoplasmic proteins of Brucella species. Clin Infect Dis. 1996;22(3):446-55.
  30. Bellaire BH, Roop RM, Cardelli J. Opsonized virulent Brucella abortus replicates within nonacidic, endoplasmic reticulum-negative, LAMP-1-positive phagosomes in human monocytes. Infect Immu. 2005;73(6):3702-13.
  31. Raj S, Saxena HM, Singh ST. Titers of Anti-Brucella Antibodies by Enzyme Linked Immunosorbant Assay in Vaccinated and Unvaccinated Brucellosis Infected Cattle. Open J Vet Med. 2017;7(10):131-7.
  32. Nelson D, Solotorovsky M. Macrophages as effectors of cell-mediated immunity. Crit Rev Microbiol. 1972;1(3):353-84.
  33. Alsubaie SA, Turkistani SA, Zeaiter AA, Thabit AK. Lack of correlation of Brucella antibody titers with clinical outcomes and culture positivity of brucellosis. Trop Dis Travel Med Vaccines. 2021;7(1):1-7.
  34. Ducrotoy MJ, Muñoz PM, Conde-Álvarez R, Blasco JM, Moriyón I. A systematic review of current immunological tests for the diagnosis of cattle brucellosis. Prev Vet Med. 2018;151:57-72.
  35. Alamian S, Esmaelizad M, Zahraei T, Etemadi A, Mohammadi M, Afshar D, et al. A novel PCR assay for detecting Brucella abortus and Brucella melitensis. Osong Public Health Res Perspect. 2017;8(1):65.
  36. Xiao P, Yang H, Di D, Piao D, Zhang Q, Hao R, et al. Genotyping of human Brucella melitensis biovar 3 isolated from Shanxi Province in China by MLVA16 and HOOF. PloS One. 2015;10(1):0115932.
  37. Zhong Z, Yu S, Wang X, Dong S, Xu J, Wang Y, et al. Human brucellosis in the People's Republic of China during 2005–2010. Int J Infect Dis. 2013;17(5):289-92.
  38. Mitka S, Anetakis C, Souliou E, Diza E, Kansouzidou A. Evaluation of different PCR assays for early detection of acute and relapsing brucellosis in humans in comparison with conventional methods. J Clin Microbiol. 2007;45(4):1211-8.
  39. Surucuoglu S, Ural S, Gazi H, Kurutepe S, Taskiran P, Yurtsever SG. Evaluation of real-time PCR method for rapid diagnosis of brucellosis with different clinical manifestations. Pol J Microbiol. 2009;58(1):15.
  40. Asaad AM, Alqahtani JM. Serological and molecular diagnosis of human brucellosis in Najran, Southwestern Saudi Arabia. J Infect Public Health. 2012;5(2):189-94.
  41. Mailles A, Ogielska M, Kemiche F, Garin-Bastuji B, Brieu N, Burnusus Z, et al. Brucella suis biovar 2 infection in humans in France: emerging infection or better recognition? Epidemiol Infect. 2017;145(13):2711-6.
  42. Cosford K. Brucella canis: An update on research and clinical management. Can Vet J. 2018;59(1):74.
  43. De Massis F, Zilli K, Di Donato G, Nuvoloni R, Pelini S, Sacchini L, et al. Distribution of Brucella field strains isolated from livestock, wildlife populations, and humans in Italy from 2007 to 2015. PLoS One. 2019;14(3):0213689.
  44. Suárez-Esquivel M, Ruiz-Villalobos N, Jiménez-Rojas C, Barquero-Calvo E, Chacón-Díaz C, Víquez-Ruiz E, et al. Brucella neotomae infection in humans, Costa Rica. 2017;23(6):997.
  45. Daood II, Zajmi A, Nouri HS, Al Jubory D. Seroprevalence of Brucellosis from the city Mosul Iraq. Int J Psychosoc Rehabilitation. 2020;24(2).
  46. Tay BY, Ahmad N, Hashim R, Zahidi M, Thong KL, Koh XP, et al. Multiple-locus variable-number tandem-repeat analysis (MLVA) genotyping of human Brucella isolates in Malaysia. BMC Infect Dis. 2015;15(1):1-7.
  47. Guler S, Kokoglu OF, Ucmak H, Gul M, Ozden S, Ozkan F. Human brucellosis in Turkey: different clinical presentations. Infect Dev Ctries. 2014;8(05):581-8.
  48. Al-Tawfiq JA, AbuKhamsin A. A 24-year study of the epidemiology of human brucellosis in a health-care system in Eastern Saudi Arabia. J Infect Public Health. 2009;2(2):81-5.
  49. Mancini F, Bella A, Graziani C, Marianelli C, Mughini-Gras L, Pasquali P, et al. Trends of human brucellosis in Italy, 1998–2010. Epidemiol Infect. 2014;142(6):1188-95.
  50. Boschiroli M-L, Foulongne V, O'Callaghan D. Brucellosis: a worldwide zoonosis. Curr Opin Microbiol. 2001;4(1):58-64.
  51. Minas M, Minas A, Gourgulianis K, Stournara A. Epidemiological and clinical aspects of human brucellosis in Central Greece. Jpn J Infect Dis. 2007;60(6):362.
52.          Soheil E, Mohammad RY, Narges K, Masoud K, Rabeeh T. The prevalence of human Brucellosis in Mazandaran province, Iran. Afr J Microbiol Res. 2012;6(19):4090-4. 

آمار
تعداد مشاهده مقاله: 765
تعداد دریافت فایل اصل مقاله: 237


counter
سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب